Tymazoline: Difference between revisions
No edit summary |
No edit summary |
||
Line 51: | Line 51: | ||
| StdInChIKey = QRORCRWSRPKEHR-UHFFFAOYSA-N | | StdInChIKey = QRORCRWSRPKEHR-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Tymazoline''' (trade name '''Thymazen''' in Poland) is a nasal [[decongestant]] that can be used to treat [[rhinitis]]. It acts as an [[antihistaminic]] and [[sympathomimetic]], reducing swelling, inflammation and mucosal secretions.<ref>[[Drugs.com]]: [http://www.drugs.com/international/tymazoline.html Tymazoline]</ref><ref>[[DrugBank]]: [http://www.drugbank.ca/drugs/DB08803 Tymazoline]</ref> | '''Tymazoline''' (trade name '''Thymazen''' in Poland) is a nasal [[decongestant]] that can be used to treat [[rhinitis]]. It acts as an [[antihistaminic]] and [[sympathomimetic]], reducing swelling, inflammation and mucosal secretions.<ref>[[Drugs.com]]: [http://www.drugs.com/international/tymazoline.html Tymazoline]</ref><ref>[[DrugBank]]: [http://www.drugbank.ca/drugs/DB08803 Tymazoline]</ref> | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Nasal preparations}} | {{Nasal preparations}} | ||
Line 61: | Line 65: | ||
[[Category:Imidazolines]] | [[Category:Imidazolines]] | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
[[Category:Drug]] | |||
Revision as of 13:58, 14 April 2015
Clinical data | |
---|---|
Trade names | Thymazen |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Nasal |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C14H20N2O |
Molar mass | 232.321 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Tymazoline |
Articles |
---|
Most recent articles on Tymazoline |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tymazoline at Clinical Trials.gov Clinical Trials on Tymazoline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tymazoline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tymazoline Discussion groups on Tymazoline Patient Handouts on Tymazoline Directions to Hospitals Treating Tymazoline Risk calculators and risk factors for Tymazoline
|
Healthcare Provider Resources |
Causes & Risk Factors for Tymazoline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis. It acts as an antihistaminic and sympathomimetic, reducing swelling, inflammation and mucosal secretions.[1][2]
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed KEGG identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Imidazolines
- Phenol ethers
- Drug